Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: Analysis of real-life data from the DPV registry from Germany and Austria

Diabetes Research and Clinical Practice

Volumn 115, Issue , 2016, Pages 31-38

  Bohn, Barbara ^a,k   Kerner, Wolfgang ^b   Seufert, Jochen ^c   Kempe, Hans Peter ^d   Jehle, Peter M ^e   Best, Frank ^f   Füchtenbusch, Martin ^g   Knauerhase, Andreas ^h   Hofer, Martin ⁱ   Rosenbauer, Joachim ^j,k   Holl, Reinhard W ^a,k  

^a UNIVERSITY OF ULM   (Germany)

^b Center of Diabetes and Metabolic Disorders   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Centre for Diabetes and Nutrition Ludwigshafen   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^f Diabetes Practice Dr Best   (Germany)

^g Practice   (Germany)

^h ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

ⁱ Karl Landsteiner Privatuniversität für Gesundheitswissenschaften   (Austria)

^j HEINRICH HEINE UNIVERSITY   (Germany)

^k GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

more..

Author keywords

Adults; Antihyperglycaemic therapy; Glycaemic control; Time trend; Type 1 diabetes; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN DERIVATIVE; LONG ACTING INSULIN; ORAL ANTIDIABETIC AGENT; SHORT ACTING INSULIN; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ANTIHYPERGLYCEMIC THERAPY; ARTICLE; AUSTRIA; BASAL SUPPORTED ORAL THERAPY; BLOOD GLUCOSE MONITORING; CHEMOTHERAPY; CONSERVATIVE TREATMENT; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; DISEASE REGISTRY; DRUG USE; FACTUAL DATABASE; FEMALE; GERMANY; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTENSIFIED CONVENTIONAL THERAPY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATIENT MONITORING; SUPPLEMENTARY INSULIN THERAPY; TREND STUDY; BLOOD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MIDDLE AGED; REGISTER; YOUNG ADULT;

ADULT; AUSTRIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN, LONG-ACTING; MALE; MIDDLE AGED; REGISTRIES; YOUNG ADULT;

EID: 84961658009     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.03.008     Document Type: Article

References (30)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. NEJM 2002, 329:977-986. The Diabetes Control and Complications Trial Research Group.
2. Holder M., Ludwig-Seibold C., Lilienthal E., Ziegler R., Heidtmann B., Holl R. Trends in der Insulinpumpentherapie bei Kindern, Jugendlichen und jungen Erwachsenen mit Typ-1-Diabetes von 1995-2006: Daten der DPV-Initiative. Diabetol Stoffwechs 2007, 2:169-174.
3. Pickup J., Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002, 25:593-598.
4. Australian Institute of Health and Welfare Insulin pump use in Australia. Diabetes series no. 18. Cat. no. CVD 58 2012, AIHW, Canberra.
5. Bode B.W., Sabbah H.T., Gross T.M., Fredrickson L.P., Davidson P.C. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002, 18(Suppl. 1):S14-S20.
6. Prescribing and Primary Care Team, Health and Social Care Information Centre Prescribing for Diabetes, England 2005-06 to 2012-13 2013.
7. Sheldon B., Russell-Jones D., Wright J. Insulin analogues: an example of applied medical science. Diabetes Obes Metab 2009, 11:5-19.
8. Alexander G.C., Sehgal N.L., Moloney R.M., Stafford R.S. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med 2008, 168:2088-2094.
9. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Long-acting insulin analogues in the treatment of diabetes mellitus type 1 2010, https://www.iqwig.de/en/search.1029.html?id=52ea8ca2-7cb8-4704-a37b-133fd5ae2962&query=insulin+analogue&language=en&page=5&group=grouped&limit=10&facet[report_type%23KurzfassungAmnog]=1&facet[information_type%235]=1&facet[report_type%23Vorbericht]=1&facet[report_type%23RapidReport]=1&facet[information_type%231]=1&facet[report_type%23Abschlussbericht]=1&filtertyp=2&von=&bis=&sort=1&sort_order=1 [accessed 12.08.15].
10. Oishi M., Yamazaki K., Okuguchi F., Sugimoto H., Kanatsuka A., Kashiwagi A. Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32). J Diabetes Invest 2014, 5:581-587.
11. Eliasson B., Eeg-Olofsson K., Cederholm J., Nilsson P.M., Gudbjörnsdóttir S. Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register. Diabetes Metab 2007, 33:269-276.
12. Hagen B, Altenhofen L, Groos S, Kretschmann J, Weber A. Qualitätssicherungsbericht 2013. Disease-Management-Programme in Nordrhein. Available at: https://www.kvno.de/60neues/2015/dmp_qualibericht2013/index.html [accessed 21.09.15].
13. Prinz N., Stingl J., Dapp A., Denkinger M.D., Fasching P., Jehle P.M., et al. High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: a multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry. Diabetes Res Clin Pract 2015, pii: S0168-8227(15)00427-1. 10.1016/j.diabres.2015.10.026.
14. Rosenbauer J., Dost A., Karges B., Hungele A., Stahl A., Bächle C., et al. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care 2012, 35:80-86.
15. Workgroup on Hypoglycemia, American Diabetes Association Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005, 28:1245-1249.
16. American Diabetes Association (ADA) Standards of medical care in diabetes - 2014. Diabetes Care 2013, 37:S14-S80.
17. Böhm B., Dreyer M., Fritsche A., Füchtenbusch M., Gölz S., Martin S. Therapie des Typ-1-Diabetes. Diabetol Stoffwechs 2013, 8:S133-S143.
18. Lee L.J., Li Q., Reynolds M.W., Engelman W. Trend analyses of insulin delivery systems in the United States. J Diabetes Sci Technol 2011, 1116-1123.
19. Monami M., Marchionni N., Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab 2009, 11:372-378.
20. Singh S.R., Ahmad F., Lal A., Yu C., Bai Z., Bennett H. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. CMAJ 2009, 180:385-397.
21. Turner L.W., Nartey D., Stafford R.S., Singh S., Alexander G.C. Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012. Diabetes Care 2014, 37:985-992.
22. Filion K.B., Joseph L., Boivin J.F., Suissa S., Brophy J.M. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf 2009, 18:973-976.
23. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes - Langfassung 2014, http://www.awmf.org/uploads/tx_szleitlinien/nvl-001gl_S3_Typ-2-Diabetes-Therapie_2014-11.pdf [21.09.15].
24. Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2014, 38:140-149.
25. Waugh N., Cummins E., Royle P., Clar C., Marien M., Richter B., et al. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation. Health Technol Assess 2010, 14:1-248.
26. Monami M., Marchionni N., Mannucci E. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract 2008, 81:184-189.
27. Miller K.M., Foster N.C., Beck R.W., Bergenstal R.M., DuBose S.N., DiMeglio L.A., et al. Current state of type 1 diabetes treatment in the U.S.: Updated data from the T1D Exchange Clinic Registry. Diabetes Care 2015, 38:971-978.
28. Ali M.K., Bullard K.M., Saaddine J.B., Cowie C.C., Imperatore G., Gregg E.W. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013, 368:1613-1624.
29. Lipska K.J., Ross J.S., Wang Y., Inzucchi S.E., Minges K., Karter A.J., et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 2014, 174:1116-1124.
30. Kim J.T., Oh T.J., Lee Y.A., Bae J.H., Kim H.J., Jung H.S., et al. Increasing trend in the number of severe hypoglycemia patients in Korea. Diabetes Metab J 2011, 35:166-172.